Stay updated with breaking news from Solara Active Pharma Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Solara Active Pharma Sciences Ltd today announced that its new state-of-the-art multipurpose API manufacturing facility at Visakhapatnam, Andhra Pradesh completed successfully the inspection carried out by the US FDA.
Solara Active Pharma Sciences Limited has successfully completed the inspection carried out by the World Health Organization at its Cuddalore facility, Tamil Nadu between January 23 – 26, 2023.
The Board of Directors of Solara Active Pharma Sciences Limited, at its meeting held today have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23 and 9MFY23.
The Board of Directors of Solara Active Pharma Sciences Limited, at its meeting held today have approved the financial results of the company for the period ended September 30, 2022 - Q2FY23 and H1FY23.
Solara Active Pharma Sciences Ltd ha announced that its new state of the art multipurpose API manufacturing facility at Vishakhapatnam, Andhra Pradesh, had received 'Certificate of Suitability' approval for the manufacture of Ibuprofen API, from EDQM.